Bossanova Investimentos

Bossanova Investimentos is one of the most active micro-VCs in Brazil, deploying high volumes of small checks (under $250k) into pre-seed and seed-stage software companies. The firm’s thesis is breadth: a portfolio strategy that places many small bets across Brazilian early-stage software, including digital health, health IT, and wellness and consumer health. For healthcare founders, Bossanova fills a specific role on a cap table, that of an early validator and Brazilian network connector, rather than that of a deep-pocketed lead.

The firm’s natural fit is with founders raising their first priced or unpriced round in Brazil, where Bossanova’s pattern recognition and network can compress diligence timelines and signal to follow-on investors. The fund is not specifically AI-focused, but its volume model means it sees a wide swath of Brazilian software including AI-tilted plays. The right founder is an early team building Brazilian B2B or B2B2C software with a clear go-to-market in the local market and a path toward larger seed or Series A in the next twelve to eighteen months. Founders raising $2M+ priced seeds with a single lead are a poor fit; this is a participation-level investor.

Geographically, the firm’s advantage is its density of relationships across Brazil’s startup ecosystem and its ability to introduce founders to angels, accelerators, and follow-on funds. For founders with no Brazilian footprint, the strategic logic is thinner. For founders building primarily for the US market, Bossanova is not a useful early partner.

The right entry path is the firm’s open application channel or a referral from an existing portfolio founder. Bossanova reads inbound at high volume; clarity, brevity, and a tight problem-solution-traction structure win. The pitch should lead with the specific Brazilian customer wedge, early evidence of demand (revenue, LOIs, paid pilots), and a credible plan for the next round. Founders should not over-engineer the AI claim; lead with commercial signal.

Caveats. The micro-VC volume model means relatively passive ongoing engagement after the check; do not expect deep operational support or specialized healthcare expertise from the partnership. Confirm what their current healthcare-specific portfolio looks like via direct reference calls before assuming the firm adds value beyond capital and signaling. For founders raising larger priced rounds, Bossanova should be a small participant alongside a real lead. As a low-friction first institutional check for early Brazilian software founders, Bossanova is a reasonable choice; as a sole lead or a healthcare-specialist partner, it is not.